Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis
about
Progestin effects on cell proliferation pathways in the postmenopausal mammary glandSteroid hormones, steroid receptors, and breast cancer stem cellsThe Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the RiskMolecular determinants of context-dependent progesterone receptor action in breast cancerIVF and breast cancer: a systematic review and meta-analysisEffects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in miceOccult breast tumor reservoir: biological properties and clinical significance.The Year in Basic Science: update of estrogen plus progestin therapy for menopausal hormone replacement implicating stem cells in the increased breast cancer risk.Live multicellular tumor spheroid models for high-content imaging and screening in cancer drug discovery.A new strategy for selective targeting of progesterone receptor with passive antagonists.Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro.Progesterone receptor action: defining a role in breast cancerDifferential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease.Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cellsGerosuppressant metformin: less is moreProgesterone action in breast, uterine, and ovarian cancers.Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a.Effect of infertility treatment and pregnancy-related hormones on breast cell proliferation in vitroMetformin: multi-faceted protection against cancer.Progesterone regulation of stem and progenitor cells in normal and malignant breastUlipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression.The biology of progesterone receptor in the normal mammary gland and in breast cancerLuteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts.The chemopreventive effect of mifepristone on mammary tumorigenesis is associated with an anti-invasive and anti-inflammatory gene signature.Progestin modulates the lipid profile and sensitivity of breast cancer cells to docetaxelProgestin regulated miRNAs that mediate progesterone receptor action in breast cancer.Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties.Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions.Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.Lysine methylation of progesterone receptor at activation function 1 regulates both ligand-independent activity and ligand sensitivity of the receptor.Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.Why does oestrogen-only hormone therapy have such a small impact on breast cancer risk? A hypothesis.Hormone replacement therapy and the risk of breast cancer.Biomarkers for breast cancer stem cells: the challenges ahead.Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells.Impact of progesterone on stem/progenitor cells in the human breast.Progesterone stimulates progenitor cells in normal human breast and breast cancer cells.Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.
P2860
Q21092903-396AFEF7-2FFA-4351-BC59-0B43AA66D329Q26799113-5521F0F8-936E-41B0-8D9A-66F83EB69C16Q26821782-1236842E-FED0-4762-8237-3BD53D5A1186Q26997928-E63EF89D-10CD-4B6E-96C9-A724D9F6BF54Q28295207-723B1300-BFEF-4A36-94FC-8DC14EEA5C32Q30353161-C18F53BC-5F42-4016-B69B-59600FF5BB9DQ30456637-BEE00E1D-A1D9-4AF1-84DF-B82BFB28C07BQ30485457-2905661B-A650-4022-A26A-D75DAF5F7AA9Q30573300-C5665E75-4EDC-47C4-A702-3FFFABFDC907Q33633141-3DFAA010-CBD2-4BFA-91DF-B71D5E648FEEQ33734466-23B6745E-3917-42B1-82FD-35502636A3C8Q33998721-382654B3-8C4E-4FEF-972A-FF8303116186Q34430545-21160AF6-51D5-4683-AE6E-801498E24780Q34483718-C65DCA13-4400-4FFE-BC57-4B2D0721B958Q35000639-0B9E9724-C95F-4969-B1B8-87F4BE5E88D0Q35052060-4D762809-6E89-4393-90DD-883E6A6D624CQ35108906-F0734823-2871-4945-85F7-35B362613806Q35150939-ADD46D38-8F1F-452C-862B-A4CBE4FA2F68Q35205643-45A6EFBE-DC96-4B08-99DB-76976138EC4EQ35620770-D51AD6A3-F9B9-4FC0-A81B-DCC5419E2FB6Q35764409-AAD76B59-9EBF-4146-A60A-F2ECB830F095Q35784828-A8ED599F-653E-4D96-890C-D5E132F3CF7AQ35810608-E078A03F-8F5C-46A0-9005-40372247761BQ35868802-0D5D8DE7-6065-44BB-AD15-8DE03BF991D5Q35986434-276B95FB-5FAC-42B2-A3BC-DA5357246121Q36220795-4311122A-8D3C-40B2-BDB2-B0C97D5E704AQ36350991-9D5B253D-02E7-434F-8BFD-9D7DD34EBACFQ36473370-8A08301E-2AC0-422F-8D29-2A876656BB3BQ36547484-9308BAB9-14DC-4A5F-B1F7-535D1B7FF764Q37091483-1251208A-0A3F-4369-9875-80ACA2E87F23Q37554700-DFE078C5-2702-4314-B0F1-A7ABEED16545Q37608465-038E701A-4454-4E04-8B14-8E8577F41E5AQ37631072-072D5385-9813-4F59-8E98-5A40DD4809F3Q37760526-B9DC65FB-E191-492C-B921-A160C07EA9BAQ37909897-7F0B1990-58B2-4C4A-9AFC-38FAC1E732F1Q37946408-58FBEBB1-8F46-4D03-BE60-422729495A55Q38373935-65387814-8710-4B32-A121-6EC77F5C1DE4Q38562815-1DFBAC2F-8DCF-4EAF-93CB-A57DA1335E33Q39036993-C952586D-FC65-4897-AAC6-FC6875CF17EBQ39262264-F879D4E4-9A18-43D8-ADB4-517A016CF8DA
P2860
Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Progestins in hormone replacem ...... g breast cancers: a hypothesis
@en
type
label
Progestins in hormone replacem ...... g breast cancers: a hypothesis
@en
prefLabel
Progestins in hormone replacem ...... g breast cancers: a hypothesis
@en
P2860
P356
P1476
Progestins in hormone replacem ...... g breast cancers: a hypothesis
@en
P2093
Carol A Sartorius
Kathryn B Horwitz
P2860
P304
P356
10.1210/JC.2008-0938
P407
P577
2008-07-22T00:00:00Z